A Look At China Life Insurance (SEHK:2628) Valuation After Strong 2025 Earnings And Proposed Final Dividend

China Life Insurance (SEHK:2628) is back in focus after reporting full year 2025 net income of CN¥154,078 million and earnings per share of CN¥5.45, alongside a proposed final dividend of CN¥0.618 per share.

See our latest analysis for China Life Insurance.

The earnings and dividend announcement comes after a 22.10% 1 month share price decline and a 14.70% year to date share price return. However, the 1 year total shareholder return of 68.20% and 3 year total shareholder return of 117.35% point to strong longer term momentum.

If this earnings move has you thinking beyond a single insurer, it could be a good moment to broaden your watchlist and check out 97 top founder-led companies

With a price of HK$24.60 per share, earnings per share (EPS) of CN¥5.45 and a proposed dividend of CN¥0.618, plus a long-term total return that is well ahead of recent price moves, is China Life still mispriced or is the market already factoring in future growth?

Most Popular Narrative: 31.7% Undervalued

China Life Insurance's most followed narrative puts fair value at HK$36.00 per share, well above the last close of HK$24.60. This frames the latest earnings in a different light.

The analysts have a consensus price target of HK$36.0 for China Life Insurance based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of HK$45.32, and the most bearish reporting a price target of just HK$28.03.

Read the complete narrative.

Want to know what sits behind that gap between current price and fair value? The narrative focuses on revenue expansion, shifting margins and a future earnings multiple that assumes investors will pay more for each dollar of profit. Curious which of those inputs has the greatest impact in the model?

Result: Fair Value of HK$36.00 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the narrative could shift if new business growth slows or if investment income proves less resilient. This would challenge assumptions on margins and future earnings power.

Find out about the key risks to this China Life Insurance narrative.

Next Steps

With sentiment clearly mixed, this is a good time to review the full data set yourself and decide how you feel about the balance of risks and rewards, starting with 5 key rewards and 2 important warning signs

Looking for more investment ideas?

If China Life Insurance has caught your attention, do not stop here, fresh ideas from different pockets of the market can sharpen your portfolio decisions.

• Spot potential value candidates early by scanning screener containing 591 high quality undiscovered gems that pair solid fundamentals with less crowded investor attention.
• Strengthen your core holdings by reviewing solid balance sheet and fundamentals stocks screener (380 results) that prioritize resilient finances and disciplined capital structures.
• Build a smoother ride through market swings by checking 263 resilient stocks with low risk scores with lower risk scores and more defensive characteristics.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com